Key Construction Projects in Guangdong Province 2023

Apr.19.2023
Key Construction Projects in Guangdong Province 2023
Guangdong Province 2023 construction plan includes four electronic cigarette-related projects, with a total investment of 585 million yuan.

Recently, the Guangdong Province 2023 Key Construction Project Plan was approved at the first session of the 14th Guangdong Provincial People's Congress. According to the notification issued by the Guangdong Provincial Development and Reform Commission, a total of 1,530 key projects will be arranged for 2023 in the province, with a total investment of CNY 8.5 trillion and an annual planned investment of CNY 1 trillion. Additionally, 1,090 provincial key preliminary construction projects will be arranged for preliminary work, with an estimated total investment of CNY 4.6 trillion.


Out of 1090 key construction projects, there are four electronic cigarette-related company factories included: Macrell, Smoore, Botton, and Han Qingda. These four projects are located in Jiangmen, Huizhou, and Foshan, with a total investment of 5.85 billion yuan.


The following project information is disclosed:


McAvell establishes electronic technology industrial park in Jiangmen.


The McGregor Electronic Technology Industrial Park Project is located in the Jianghai district of Jiangmen city, Guangdong province.


The total project investment amounts to 3 billion yuan. As of the end of 2022, a cumulative investment of 1 billion yuan has been completed, with plans to invest an additional 200 million yuan in 2023.


The project involves the construction of new factory buildings for the production of high-end electronic atomizer core components and other electronic device manufacturing.


The construction period will start in 2019 and end in 2024.


McWherter Project Information | Image source: Guangdong Provincial Development and Reform Commission


Simula establishes new materials technology industrial park in Jiangmen.


The Simore New Materials Technology Industrial Park project is located in Jiangmen City, Guangdong Province, China.


The total project investment is 1 billion yuan. As of the end of 2022, 36 million yuan has been invested cumulatively, and there are plans to invest 150 million yuan in 2023.


The project construction includes the establishment of a research, development, production, and sales headquarters for electronic heating elements and atomized materials.


The construction period is from 2022 to 2025.


Smor Project Information | Image Source: Guangdong Development and Reform Commission


China's "Boton" has built its Zhongkai "Boton" electronic atomizer headquarters and intelligent manufacturing base in Huizhou.


The headquarters and intelligent manufacturing base project of Zhongkai Podton Electronic Atomizer in China is located in Huizhou City, Guangdong Province.


The total investment of the project is 1.2 billion yuan, with plans to invest an additional 500 million yuan in 2023.


The construction project includes the production and operation of electronic atomizers, medical equipment and other related products.


The construction is scheduled to take place from 2023 to 2025.


Information about China's Bode project | Image source: Guangdong Development and Reform Commission.


Hanqingda establishes High Ming Intelligent Manufacturing Base in Foshan.


The HQD project for the construction of a high-tech manufacturing base is located in the Hecheng Street area of Foshan City, Guangdong Province.


The total investment in the project is 650 million yuan, with plans to invest an additional 100 million yuan by 2023.


The construction project includes facilities such as an e-cigarette production plant and planned supporting infrastructure like the first and last transit stops.


The construction period for the project is from 2023 to 2025.


Project Information of Hanqingda | Image Source: Guangdong Provincial Development and Reform Commission


For more related news, please follow 2FIRSTS.


Further Reading:


Semiconductor manufacturer SMIC reports a 97.7% decrease in revenue in the Chinese mainland market for the first quarter, while overseas markets experience a growth of 58.2%.


Macquarie plans to buy 3.5 billion yuan of structured deposits from Bank of China.


China's Boton is reportedly planning to purchase industrial land in Huizhou to construct a new headquarters and a manufacturing base for electronic atomizers.


References:


Notice from Guangdong Provincial Development and Reform Commission regarding the issuance of the 2023 major construction project plan for Guangdong Province.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives